Chronic lymphocytic leukaemia

Author: Louise Newson, general practitioner, Solihull. Reviewed by Donald Milligan, oncologist Birmingham. Updated by Emma Lackey, general practitioner Newcastle upon Tyne.
Chronic lymphocytic leukaemia

Key learning points

  • Chronic lymphocytic leukaemia (CLL) is a malignancy of B-lymphocyte cells.
  • It is the commonest type of leukaemia in the UK, predominantly affecting older people, often found incidentally on a blood test taken for another reason.
  • Symptoms can include frequent infections, enlarged lymph nodes and tiredness.
  • If any leukaemia is suspected in an adult, a full blood count (FBC) should be performed within 48 hours.
  • Treatment decisions are based on factors including patient symptoms, comorbidities and preferences, disease staging and the presence of specific molecular markers.
  • Treatment may begin with a watch and wait policy, followed by active treatment.
  • While CLL is not usually curable, the slow progression of the disease means many people die of other unrelated conditions.

To view full article register to OnMedica and then click
'View full content'. 


Comments are disabled